Heerarka Guusha IVF ee Hindiya: Maxay Lammaanuhu tahay inay ogaadaan 2026

10/6/2026, 8:08:36 PM 10 daqiiqo akhri Dalxiiska Caafimaadka
Heerarka Guusha IVF ee Hindiya: Maxay Lammaanuhu tahay inay ogaadaan 2026

Meel u dhaxaysa wareegga saddexaad ee guuldareystay iyo ballanta shanaad ee takhasuska leh, inta badan lamaanayaasha waxay joojiyaan weydiinta in IVF ay shaqeyn doonto iyo inay bilaabaan inay weydiiyaan halka ay dhab ahaantii awoodi karaan inay ogaadaan. Ururka Caafimaadka Adduunka ayaa ku qiyaasay in ku dhawaad1 ka mid ah 6 dadka waaweyn ee adduunka oo dhanmadhalaysnimo la kulmaan mar uun noloshooda. Taasi waa qiyaastii 17.5% dadka qaangaarka ah ee adduunka. Hindiya oo keliya, qiyaas28 milyan oo lamaanela kulan su'aasha la mid ah.

 

Lamaanayaasha caalamiga ah, caqabada kharashka ayaa inta badan ah waxa dhameeya wada hadalka ka hor inta aan daawaynta bilaabmin. Hal wareeg oo IVF ah oo gudaha Maraykanka ah ayaa caadiyan socda inta u dhaxaysa USD 15,000 iyo USD 30,000. Gudaha Hindiya, isla wareegtada xarunta bacriminta ee la aqoonsan yahay ayaa u dhaxaysaUSD 2,500 iyo USD 4,500. Hindiya hadda waxay qabataa qiyaas ahaan250,000 ilaa 300,000 IVF wareegyada sannadkii, iyo xarumaha bacriminta ee dalka ugu horeeya waxay ka warbixiyaan heerarka guusha kuwaas oo si raaxo leh ula fadhiya heerarka caalamiga ah.

 

Laakiin waxa jira qayb ka mid ah sheekadan oo ka muhiimsan lambarka cinwaanka. Heerarka guusha IVF waxay si aad ah ugu xiran yihiin waxa la cabbirayo, tignoolajiyada rugta caafimaadku dhab ahaantii isticmaasho, iyo da'da bukaanka. In si sax ah loo helo macnaha guud ka hor intaadan dooran meel aad u socoto ayaa wax walba beddesha.

 

Maxay tahay sababta ay tirooyinka guusha IVF ugu kala duwan yihiin rugaha caafimaadka?

Soo gal rug kasta oo bacrin ah oo ku taal Hindiya oo weydii heerka guusha. Fursadaha ayaa ah, hal xarun caafimaad waxay leedahay 65%, mid kalena wuxuu leeyahay 40%, mid saddexaadna wuxuu leeyahay 80%. Saddexduba run bay sheegi karaan. Waxyaabo kala duwan uun bay cabbirayaan.

 

Rugaha caafimaadka qaarkood waxay soo sheegaan heerka uur-qaadista bukaan-socod ee bukaan-socodka, kaas oo xisaabinaya garaaca wadnaha ee la xaqiijiyay ee ultrasound-ka. Kuwo kale waxay soo sheegaan heerka galinta embriyaha ee la wareejiyo. Shaxda ugu daacadsan iyo kiliinikada waxtarka leh ayaa ahheerka dhalashada noolaha halkii wareeg ayaa bilaabmay, taasoo la micno ah inta jeer ee wareegga IVF dhamaystiran uu keeno ilmo dhasha. Kani had iyo jeer waa kan ugu hooseeya ee saddexda lambar, waana ta kaliya ee dhab ahaantii ka jawaabeysa su'aalaha lamaanayaasha iswaydiinayaa.

 

Farqiga u dhexeeya heerka uurka ee bukaan-socodka iyo heerka dhalashada nool ee isla rugta caafimaadka waxay noqon kartaa meel kasta oo u dhaxaysa 10 ilaa 20 dhibcood. Rugta caafimaadka ee ka warbixisa 65% guusha waxa laga yaabaa inay tiriso uur la xaqiijiyay. Qiyaasta dhalashadooda nool ee wareeg kasta waxay noqon kartaa ku dhawaad ​​45%. Midkoodna daacadnimo ma aha, laakiin mid keliya ayaa ka jawaabaya su'aasha saxda ah.

 

Kahor intaanay aqbalin wax shax ah, lamaanayaashu waa inay si toos ah u weydiiyaan: lambarkani ma wuxuu ku salaysan yahay dhalmo nool ama uur la xaqiijiyay, oo miyaa la cabbiraa wareegga bilaabma mise embriyaha ayaa la wareejiyaa? Rug kasta oo sumcad leh ayaa ka jawaabi doonta si aan shaki lahayn.

 

Intee in le'eg ayay da'du runtii beddeshaa khayaalka?

In ka badan inta bukaanada badankoodu filayaan. Tayada ukunta iyo sharafta koromosoomyada ayaa hoos u dhacda marka ay da'du jirto siyaalo aan hab-maamuuska kicinta ama farsamada shaybaarku si buuxda u beddeli karin. Waa xaqiiqo nafley ah oo meel walba khuseysa.

 

  • Waayodumarka ka yar 35 sano, Heerarka dhalashada nool ee wareeg kasta ee xarumaha ugu horreeya ee Hindiya fadhiya inta u dhaxaysa40 iyo 55%.
  • Haweenka 30 ka yaroo leh kayd caafimaad qaba ugxan-sidaha oo aan lahayn xaalado hoose oo muhiim ah oo matalayamusharaxiinta ugu adag ee guushahal wareeg.
  • Haweenka 35 ka yar ee qabaweligeed hore uma uuraynagagaarka a32%fursad uu ku uurayn hal wareeg oo IVF ah, taasoo kor u kacday ilaa 37% kuwii ilmo hore u lahaa. Tignoolajiyada horumarsan, tani waxay gaari kartaa ilaa 55.6% hal wareeg oo soo-saar ukun ah.
  • Inta u dhaxaysa 35 iyo 37, heerka meerto kasta wuxuu hoos ugu dhacaa qiyaas ahaan30-40%. Hoos u dhaca ayaa soo dedejiya 38 ka dib.
  • Waayodumarka da'doodu u dhaxayso 38 ilaa 40kooxda da'da, heerka guushu wuxuu u dhexeeyaa inta u dhaxaysa20.2 iyo 26.8%iyadoo ku xiran arrimaha dhalmo la'aanta hoose.
  • Laga bilaabo 41 ilaa 42, Ukun iska leh IVF waxay dhalisaa dhalmo nool gudaha12 ilaa 18%wareegyada.

Ku-deeqaha beedka IVFwaa ka duwan yahay. Sababtoo ah ukumaha deeq-bixiyeyaashu waxay ka yimaadaan haweenka da'doodu u dhaxayso 21 ilaa 34, heerka dhalashada noolaha ee wareeg kasta wuxuu u dhexeeyaa50% ilaa 65%iyadoon loo eegin da'da qaataha. Haweenka 40 ka weyn ee aan hadda ku guulaysan ugxantooda, ku-deeqaha beedka IVF ma aha ikhtiyaar nasteexo. Badanaa waa dariiqa hore ee caddaynta ugu badan.

Tirakoobka hal-wareeg ah ayaa qarinaya run ka weyn. Haweeney 35 jir ah oo leh 40% heerka guusha wareeggii kasta waxa laga yaabaa in ay gaadho guul wadareedka 70-80% in ka badan 3 wareeg. Qorshaynta isku dayo badan, halkii mid kasta loola dhaqmi lahaa sidii dhacdo keligiis ah, waxay keentaa go'aamo wanaagsan iyo gabagabo dhicis ah oo yar.

 

Waa maxay Tiknoolajiyada ka sooca shaybaarka IVF ee Wanaagsan ee Mid ka mid ah?

Tani waa su'aasha inta badan lamaanayaasha ay illoobaan inay isweyddiiyaan, waana arrin aad uga muhimsan ku dhawaad ​​wax kasta oo kale oo ay xakameyn karaan.

Sayniska aasaasiga ah ee IVF si weyn isuma beddelin muddo tobanaan sano ah: soo saar ukun, ku bacrin shaybaar, dhaqan embriyaha ka soo baxa, oo u gudbi midka ugu fiican ilmo-galeenka. Waxa is beddelay waa sida saxda ah ee mid kasta oo tallaabooyinkaas ka mid ah loo fulin karo. Farqiga u dhexeeya xarun bacrin ah oo Hindi ah oo si fiican u qalabaysan iyo mid aasaasi ah ayaa ka muuqda natiijooyinka.

 

ICSI, duritaanka shahwada intracytoplasmic, waxay ku lug leedahay in hal shahwo oo la doortay si toos ah loogu duro ukun kasta halkii la isku dari lahaa shahwada iyo ukunta oo la rajeynayo bacriminta. Waxaa loo horumariyaymadhalaysnimo-ragoo ay ku jiraan tirada shahwada oo hooseeya, dhaq-dhaqaaq xumo, iyo kala qaybsanaan sare oo DNA ah. Xarumaha ugu horeeya ee Hindiya, ICSI waa halbeeg oo qiimaheedu waa qiyaastiiINR 20,000 ilaa 80,000 INRmarka lagu daro khidmadda wareegga saldhiga. Lammaanaha halka qodobka lab uu ka qayb qaadanayo bacriminta fashilantay, faraqa u dhexeeya IVF-ta caadiga ah iyo ICSI maaha mid xad dhaaf ah.

 

PGT-A(baaritaanka hidde-sidaha preimplantation ee aneuploidies) waxay baartaa uurjiifka cilladaha koromosoomyada ka hor inta aan la gaarin go'aan wareejin kasta. Halkii laga dooran lahaa embriyaha iyadoo lagu salaynayo muuqaalkiisa mikroskoob, kooxdu waxay doorataa kaliyaembriyaha caadiga ah ee koromosoomyadawareejinta. Tani waxay aad u khusaysaa dumarka ka wayn 35 sano iyo lamaanayaasha dhicis soo noqnoqda. Imtixaanka PGT-A waa qiyaastiiINR 50,000 ilaa INR 1,50,000 wareeggiibaXarumo Hindi ah oo la aqoonsan yahay, oo ay la socdaan shaybaaro hidde-sidayaal dibadeed oo la aqoonsan yahay.

 

Maxay yihiin Tignoolajiyada wax ka qabanaya Ku-tallaalka Dhicisoobay?

Nidaamyada kormeerka waqti-dhaafka ah, oo ay ku jiraanEmbryoScope, Ku hay embriyaha gudaha kulaytarka xasiloon halka kamarad ku dhex jirta ay sawirto dhowrkii daqiiqoba mar. Shaybaadhka caadiga ah, embriyaha ayaa subax kasta laga saaraa si loogu fiirsado, si kooban u kashifaya heerkulka iyo isbeddelka gaasta. Waqti-dhaafku wuxuu meesha ka saarayaa carqaladayntaas iyowaxay abuurtaa rikoor koritaan oo joogto ahtaas oo ka caawisa embriyaha in ay ogaadaan embriyaha ee leh awooda ugu adag ee la geliyo.

 

Falanqaynta soo dhaweynta endometrial (ERA)waxay ka hadlaysaa sabab gaar ah, oo inta badan la iska indho-tiray oo ah sababta soo noqnoqota ee ku-tiirsanaanta. Habka wareejinta embriyaha barafaysan ee caadiga ah waxa uu u malaynayaa in dhammaan dumarka ay haystaan ​​daaqadda tallaalka ugu sarreysa isla goobta wareegga diyaarsan. ERA waxay tijaabinaysaa biopsi endometrial sisi sax ah u aqoonso marka qofka bukaanka ah daaqadiisa uu furmo, kaas oo ka duwanaan kara 12 ilaa 48 saacadood marka loo eego celceliska la filayo. Lammaanayaasha leh wareejinta badan ee guuldarreystay ee leh embriyaha tayada wanaagsan iyo daloolka ilmo-galeenka caadiga ah, ERA waxay beddeshaa waqtiga wareejinta waxayna badiyaa beddeshaa natiijada. Imtixaanku waa qiyaastiiINR 35,000 ilaa INR 60,000xarumaha Hindiya.

 

Vitrification, farsamada degdega ah ee barafyada loo isticmaalo embriyaha iyo kaydinta ukunta, ayaa bedeshay waxa wareejinta embriyaha barafaysan uu gaadhi karo. Hababka qadiimka ah, ee qunyar u qaboojinta ayaa sababay waxyeello baraf-crystal ah, yaraynta badbaadada embriyaha iyo tayada dhalaalid ka dib. Vitrification ayaa gaadhaHeerarka badbaadada embriyaha ee 95% ama ka sareeya, iyo wareegyada wareejinta embriyaha barafaysan ee xarumaha ugu horeeya ee Hindiya ayaa hadda soo saara heerar dhalmo nool oo la mid ah ama ka wanaagsan wareejinta cusub ee kooxo badan oo bukaan ah.

 

Macnaha la taaban karo ayaa ah in lammaanaha soo saara embriyaha tayada wanaagsan ee hal wareeg oo dib u soo celin ah ay u isticmaali karaan isku dayo badan oo wareejin ah iyada oo aan kharash ama baahi jireed oo soo noqnoqonaysa kicinta.

 

Waa maxay kharashka daawaynta IVF buuxda ee Hindiya?

IVF ee HindiyakharashkaUSD 2,500 ilaa 4,500waxayna dabooshaa la socodka kicinta ugxansidaha, dib u soo celinta ukunta ee suuxinta, dhaqanka uurjiifka, iyo hal wareejin cusub oo uurjiif ah. Waa dhif in ay ku jiraan wax walba.

 

Daawooyinka kicinta, kuwaas oo lagu qoray iyadoo lagu saleynayo heerarka AMH ee bukaanka iyo tirada follicle-ka antraral, sida caadiga ah ku darINR 50,000 ilaa INR 1,50,000wadarta guud. Kuwan ayaa inta badan laga saaray qiimaha xirmada cinwaanka. Kharashka suuxinta ayaa marmar si gaar ah loo dallacaa. Nidaam kasta oo lagu daro oo ay ku jiraan ICSI, PGT-A, ERA, ama dillaacinta la caawiyay waxay wataan kharashkooda.

 

Awareegga wareejinta embriyaha barafaysan, halka embriyaha vitrified ka soo saarid hore la dhalaaliyay oo la wareejiyo, kharashyadaINR 50,000 ilaa INR 90,000marka lagu daro wareegga saldhiga.Qiimaha kaydinta embriyahakala duwanINR 10,000 ilaa INR 20,000 sanadkii.

 

Wareegyada ukunta deeq bixiyayaashaku darINR 70,000 ilaa INR 1,50,000ilaa qiimaha daaweynta aasaasiga ah ee magdhowga deeq bixiyayaasha iyo baaritaanka.

 

Qiimaha la soo xigtay aad bay ugu kala duwan yihiin rugaha caafimaadka, iyo xirmada ku darida way ka duwan yihiin xarun ilaa xarun kale. Waxa ugu faa'iidada badan ee lammaanuhu samayn karaan ka hor isbarbardhigga rugaha caafimaadka waa inay codsadaan qiyaas dhammaystiran oo ay ku jiraan dawooyinka, suuxinta, iyo dhammaan hababka kordhinta ee la filayo, ma aha oo keliya cinwaanka cinwaanka qiimaha xirmada IVF.

 

Sidee IVF loogu maamulaa Hindiya?

Qaybta IVF ee Hindiya waxaa maamulaSharciga Tignoolajiyada Taranka ee Caawinta, 2021Sharcigu wuxuu u baahan yahay dhammaan xarumaha ART inay iska diwaan geliyaan Diiwaanka Qaranka, dejiyaan shuruudaha u-qalmitaanka deeq bixiyayaasha, qeexaya borotokoolka kaydinta, oo faraya heerarka ilaalinta diiwaanka caafimaadka.

 

TheDiiwaanka ART ee Qaranka Hindiya (NARI), oo ay maamusho Golaha Hindida ee Cilmi-baarista Caafimaadka (ICMR), waxay diiwaan gelisaa rugaha caafimaadka waxayna uruurisaa xogta natiijada qaranka. Rugaha caafimaadka haystaAqoonsiga NABHku shaqeeya shaybaadhka iyo heerarka tayada caafimaad ee la qeexay. Xeerka ART ee 2025 ayaa mar hore horseeday in la xidho dhawr rug caafimaad oo aan ka diiwaan gashanayn Waqooyiga Hindiya, taas oo yaraynaysa farqiga u dhexeeya hab-dhaqanka la habeeyey iyo kuwa aan sharciyeysnayn.

 

Xidhiidhka Hindiya ee IVF wuxuu dib u soo noqday in ka badan inta bukaannada badankoodu ogaadaan.Ilmaha labaad ee adduunka IVF iyo kan ugu horreeya Hindiya, Kanupriya, waxa uu dhashay Oktoobar 3, 1978, iyada oo loo marayo shaqada Dr Subhas Mukherjee iyo asxaabtiisa Kolkata. Mukherjee sidoo kale wuxuu ahaa kii ugu horreeyay ee adduunka u isticmaala gonadotropins kicinta ugxan-sidaha ee IVF iyo in la qaboojiyo oo dhalaalo embriyaha bini'aadamka ka hor inta aan la wareejin. Qoto dheer ee hay'adaha ee qaybta bacriminta Hindiya maanta ma aysan iman dhawaan.

 

Maxaa Kale Oo Saameeya Natiijooyinka Ka Baxa Da'da?

  • Kaydka ugxan-sidahawaa saadaasha dheeraadka ah ee ugu waxtarka badan. Baaritaanka AMH iyo tirinta follicle-ka antral ee loo maro ultrasound transvaginal u sheeg kooxda bacriminta inta ukun ee wareegga kicinta ay u badan tahay inuu soo saaro. AMH hoose kama saarayso IVF, laakiin waxay bedeshaa habka kicinta iyo rajada laga filayo inta uurjiif ah ayaa diyaar u noqon doona xulashada ama qaboojinta.
  • Dhalmo la'aanta raggahadda waxay ka dhigan tahay 40 ilaa 50% kiisaska Hindiya, marka loo eego xogta caafimaad ee la daabacay. Falanqaynta caadiga ah ee shahwada waxay cabbirtaa tirinta iyo dhaqdhaqaaqa, laakiin tijaabada kala qaybsanaanta DNA-da shahwada ayaa sii socota. AShahwadda jajabinta DNA-da (DFI)Ka sarreeya 25 ilaa 30% waxay yaraynaysaa heerka bacriminta iyo tayada embriyaha xitaa marka cabbirada shahwada caadiga ahi ay u muuqdaan kuwo caadi ah. Xarumaha Hindiya ee hormuudka ka ah, baaritaanka DFI ayaa hagaya in ICSI oo leh shahwad daacad ah oo la doortay la dammaanad qaaday iyo in kale.
  • Anatomy uterineinearrimo ka badan inta bukaanno badan loo sheego.Fibroidstaasoo qalloocisa godka ilmo galeenka.polyps endometrial, iyo septum uterineine kulligood waxay wax u dhimi karaan beerista iyada oo aan loo eegin tayada embriyaha. Hysteroscopy ka hor wareegga wareejinta koowaad, ama ka hor wareegga kasta ee bukaanka qaba cillad aan la garanayn, waxay xaqiijinaysaa in deegaanka ilmo-galeenka uu diyaar u yahay anatomically.
  • PCOSsaameeyaa ilaa10% haweenka da'da tarankawaxayna u baahan tahay borotokoolka kicinta oo la bedelay si looga fogaado xuubka hyperstimulation syndrome (OHSS). Xarumaha Hindida ee la aqoonsan yahay, bukaanada PCOS ee raacaya hab-maamuuska la hagaajiyay waxay si joogto ah u gaadhaan natiijooyin u dhigma kuwa da'da u dhigma ee aan PCOS ahayn.

 

Waa maxay su'aalaha ay tahay in lammaanaha caalamiga ahi ay isweyddiiyaan ka hor inta aanay dooran xarun?

  1. Xaruntu miyay ka warbixisaa heerarka dhalmada noolka ah ee wareeg kasta bilaabay, oo ay u qaybiyeen koox da'? Weydii tiradan si gaar ah, ha u waydiin heerka uurka ee bukaan-socodka.
  2. Shaybaadhka Embryology-ga NABH ma yahay mid la aqoonsan yahay mise ICMR-ka diwaangashan, oo ma u isticmaashaa kuleejka waqti-dhaafka ah heer ahaan?
  3. Xaruntu ma bixisaa baaritaanka PGT-A iyada oo la falanqeynayo shaybaar hidde-sidayaasha dibadeed shahaadeysan, iyo xaaladdee ayay kooxdu ku talinaysaa?
  4. Sidee xaruntu u maareysaa jawaab-bixiyeyaasha hoose iyo bukaannada PCOS, iyo waa maxay borotokoolka kicinta ee ay isticmaasho iyadoo lagu salaynayo AMH iyo AFC bukaanka?
  5. Xaruntu miyay khibrad u leedahay daawaynta bukaanada caalamiga ah, oo ma leedahay isuduwaha maamula baadhitaanka imaanshaha ka hor iyo qorshaynta ka saarida dabagalka dibada?
  6. Maxay ku jirtaa qiyaasta qiimaha si buuxda loo qeexay, iyo alaabtee si gooni ah looga dallacay xirmada IVF ee saldhiga?

 

Gabagabadii

Heerarka guusha IVF maaha guryaha go'an ee rugta caafimaadka. Waxay yihiin natiijooyin ka dhashay isdhexgalka ka dhexeeya bayoolaji bukaanka, awoodaha shaybaadhka, go'aamada borotokoolka dhakhtarka, iyo wakhtiga daawaynta.

 

Lamaanihii yimid xarun taran oo Hindi ah oo si fiican u qalabaysan oo AMH iyo AFC horayba loo qiyaasay, hab-maamuuska kicinta ee shakhsi ahaan loo sameeyay, PGT-A ayaa lagu dabaqay xulashadooda embriyaha, iyo istaraatiijiyad lagu taageerayo qaboojinta-dhammaan istaraatiijiyadda meesha taal maaha mid isku mid ah oo tirakoobka ah sida lammaanaha imanaya iyada oo aan midna shaqadaas aasaaska ah la samaynin iyo tiro tix-raac ah oo laga soo qaatay bogga internetka oo keliya.

 

Afeef:Maqaalkani wuxuu bixiyaa macluumaadka guud ee waxbarashada ee ku saabsan daaweynta IVF iyo heerarka guusha ee Hindiya. Ma aha talo-bixin caafimaad, mana aha in lagu beddelo la-talinta takhasuska bacriminta ama takhtarka daawaynta taranka. Natiijooyinka shakhsi ahaaneed way kala duwan yihiin iyadoo ku saleysan da'da, kaydka ugxan-sidaha, cabirrada shahwada, anatomy uterineine, tayada uurjiifka, iyo borotokoollada gaarka ah ee rugta caafimaadka. Lammaanuhu waa inay la tashadaan khabiir ku takhasusay daawaynta taranka ka hor intaysan samayn wax go'aanno daaweyn ah.

Isbitaalada la xiriira

Baro Isbitaalada iyo xarumaha caafimaadka ee la xiriira mowduucan adeegyada daryeelka caafimaadka tayada leh.

Park Medical Bahcelievler Hospital
Platinum

Park Medical Bahcelievler Hospital

Istanbul, Turkiga

Medical Park Bahcelievler Hospital waa cisbitaal la aqoonsan yahay JCI oo leh 242 sariirood oo ku yaal Istanbul, oo la aasaasay 2007. Ku faafaya 33,00...

Multi-specialty
Aasaasay 2007
242 sariiraha
Aqoonsado
Joint Commission International (JCI)
Gadawiya xarumaha
+13
BLK-Max Super Specialty Hospital, New Delhi
Platinum

BLK-Max Super Specialty Hospital, New Delhi

New Delhi, Hindiya

BLK-Max Super Specialty Hospital ee New Delhi waa mid ka mid ah xarumaha daryeelka caafimaadka ee Hindiya, oo bixiya 650 sariirood, 22 tiyaatar qallii...

Multi-specialty
Aasaasay 1959
650 sariiraha
Aqoonsado
Joint Commission International (JCI)
National Accreditation Board for Hospitals & Healthcare Providers (NABH)
Gadawiya xarumaha
+13
Fortis Memorial Research Institute (FMRI), Gurgaon
Platinum

Fortis Memorial Research Institute (FMRI), Gurgaon

Gurgaon, Hindiya

Fortis Memorial Research Institute (FMRI), Gurgaon, waa isbitaal heer caalami ah oo badan oo takhasus leh oo la aasaasay 2013. Isbitaalku wuxuu bixiya...

Multi-specialty
Aasaasay 2013
330 sariiraha
Aqoonsado
Joint Commission International (JCI)
National Accreditation Board for Hospitals & Healthcare Providers (NABH)
Gadawiya xarumaha
+13
Isbitaalka Artemis, Gurgaon
Platinum

Isbitaalka Artemis, Gurgaon

Gurgaon, Hindiya

Cisbitaalka Artemis, Gurgaon, waa cisbitaalka takhasuska badan ee JCI la aqoonsan yahay oo la aasaasay 2007. Waxa uu bixiyaa 750+ sariirood iyo kaabay...

Multi-specialty
Aasaasay 2007
750 sariiraha
Aqoonsado
Joint Commission International (JCI)
National Accreditation Board for Hospitals & Healthcare Providers (NABH)
International Organization for Standardization (ISO)
Gadawiya xarumaha
+13
Isbitaalka Kokilaben Dhirubhai Ambani, Mumbai
Platinum

Isbitaalka Kokilaben Dhirubhai Ambani, Mumbai

Mumbai, Hindiya

Kokilaben Dhirubhai Ambani Hospital, Mumbai, waa JCI, NABH, NABL, iyo CAP-la aqoonsan cusbitaalka daryeelka afargeesoodka ah oo la aasaasay 2009. Iyad...

Multi-specialty
Aasaasay 2009
750 sariiraha
Aqoonsado
Joint Commission International (JCI)
National Accreditation Board for Hospitals & Healthcare Providers (NABH)
International Organization for Standardization (ISO)
Gadawiya xarumaha
+13
Isbitaalada Medicover, Hitech City, Hyderabad
Platinum

Isbitaalada Medicover, Hitech City, Hyderabad

Hyderabad, Hindiya

Isbitaalada Medicover, Hitech City, Hyderabad, waa 400-sariirood oo NABH ah oo la aqoonsan yahay cosbitaal sare oo gaar ah oo la aasaasay 2011. Waa qa...

Multi-specialty
Aasaasay 2011
400 sariiraha
Aqoonsado
National Accreditation Board for Hospitals & Healthcare Providers (NABH)
Joint Commission International (JCI)
Gadawiya xarumaha
+13

Dhakhaatiirta la xiriira

Ku xir dhakhaatiir khibrad leh iyo khabiiro caafimaad oo arimahan ah.

Dr. Radhamony D

Dr. Radhamony D

La-taliye sare

40 sano khibrad
Dr. Sushma Prasad Sinha

Dr. Sushma Prasad Sinha

La-taliye sare

35 sano khibrad
Dr. Suresh Kumar Rawat

Dr. Suresh Kumar Rawat

La-taliye sare

42 sano khibrad
Dr. Rupali Goyal

Dr. Rupali Goyal

La-taliye sare

30 sano khibrad
Dr. Sohani Verma

Dr. Sohani Verma

La-taliye sare

40 sano khibrad

Maqaallada la xiriira

Sahamiyaan maqaallo badan iyo aragtiyo ku saabsan mowduucyada caafimaadka ee la midka ah.

Qaliinka Tummy Tuck ee Hindiya: Qiimaha, Soo kabashada, Farsamooyinka, iyo Natiijooyinka
Dalxiiska Caafimaadka

Qaliinka Tummy Tuck ee Hindiya: Qiimaha, Soo kabashada, Farsamooyinka, iyo Natiijooyinka

11/6/2026, 7:02:43 AM
9 daqiiqo akhri
Waxaa jira jahawareer gaar ah oo dadka u keena la-tashiga caloosha. Hawshii way qabteen. Miisaanka ayaa tagay, ama uurkii ayaa dhammaaday, ama labadab...
Dib-u-dhiska Naaska Kadib Qaliinka Kansarka Naasaha
Dalxiiska Caafimaadka

Dib-u-dhiska Naaska Kadib Qaliinka Kansarka Naasaha

11/6/2026, 6:14:49 AM
11 daqiiqo akhri
Wadahadalka ku saabsan dib u dhiska naasaha wuxuu caadi ahaan dhacaa waqtiga ugu xun ee suurtogalka ah. Haweeney ayaa hadda loo sheegay inay u baahan ...
Rhinoplasty ee Hindiya: Qiimaha, Farsamooyinka Cusub, iyo Soo kabashada
Dalxiiska Caafimaadka

Rhinoplasty ee Hindiya: Qiimaha, Farsamooyinka Cusub, iyo Soo kabashada

11/6/2026, 5:58:34 AM
10 daqiiqo akhri
Dhammaan hababka isqurxinta ee bukaanku u safraan dibadda, rhinoplasty waa kan leh saamiga ugu sarreeya iyo heerka ugu yar ee qaladka. Sanku wuxuu ku ...
Sababta IVF u Fashilanto: Sababaha Caadiga ah iyo Waxa Xiga La Sameeyo
Dalxiiska Caafimaadka

Sababta IVF u Fashilanto: Sababaha Caadiga ah iyo Waxa Xiga La Sameeyo

10/6/2026, 8:51:09 PM
13 daqiiqo akhri
GuuldaraystayIVFmeertadu waa nooc murugo gaar ah. Si ka duwan khasaaraha kale ee bacriminta, waxay timaaddaa toddobaadyo irbado ah ka dib, la socodka ...
IVF vs IUI: Farqiga, Heerarka Guusha, Qiimaha, iyo daawadee adiga kugu habboon
Dalxiiska Caafimaadka

IVF vs IUI: Farqiga, Heerarka Guusha, Qiimaha, iyo daawadee adiga kugu habboon

10/6/2026, 8:35:36 PM
10 daqiiqo akhri
Qofna ma yimaado rugta dhalmada isagoo rajeynaya inuu u baahdo IVF. Lammaanayaasha intooda badani waxay ku bilaabaan rajo xasilloon oo ah in wax ka fu...
Ukunta Qaboojinta Dibadda: Wadamada ugu Fiican, Kharashyada, iyo waxa la filayo
Dalxiiska Caafimaadka

Ukunta Qaboojinta Dibadda: Wadamada ugu Fiican, Kharashyada, iyo waxa la filayo

10/6/2026, 8:23:16 PM
10 daqiiqo akhri
Su'aasha inta badan dumarka ay la yimaadaan waa mid sahlan oo ku filan: aad bay u daahday? Badanaa waa 33, ama 36, ama 38. Waxay hayaan shaqo adag, am...

Qorto

All
Dr. Deepanshu Siwach

Sr. Qoraa Caafimaad

Sr. Qoraa Macluumaadka Caafimaadka Caafimaadka iyo Caafimaadka Qoonaq
Dhakhtarka Farmashiyaha

Dr. Deepanshu Siwach waa farmashiistaha kiliinikada ee khibrada leh oo haysta shahaadada Dhakhtarka Farmashiyaha. Wuxuu leeyahay waayo-aragnimo 4 sano ka badan wuxuuna la shaqeeyay kumanaan bukaan ah... Akhri wax dheeraad ah

Websaydhkeenu wuxuu adeegsadaa cookies. Qaanuunka Arrimaha Khaaska ah.